Dr. Whelan and colleagues reply

New England Journal of Medicine

Volumn 373, Issue 19, 2015, Pages 1878-1879

  Whelan, Timothy J ^a   Olivotto, Ivo A ^b   Levine, Mark N ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Baker Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREATH HOLDING; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR MORTALITY; HEART DISEASE; HUMAN; INTERNAL MAMMARY NODE; LETTER; LYMPH NODE; LYMPH NODE IRRADIATION; LYMPHOSCINTIGRAPHY; PATIENT SELECTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SUPRACLAVICULAR LYMPH NODE; TUMOR RECURRENCE; BREAST NEOPLASMS; FEMALE; LYMPHATIC METASTASIS; THORAX WALL;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; THORACIC WALL;

EID: 84946112784     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1510505     Document Type: Letter

References (3)

1. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368: 987-98.
2. Bartlett FR, Colgan RM, Carr K, et al. The UK HeartSpare Study: Randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. Radiother Oncol 2013;108: 242-7.
3. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillarylymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8: 881-8.